MabVax Therapeutics MBVX 2017 Corporate Presentation

MabVax Therapeutics Holdings, Inc. updated corporate presentation filed via Form 8-K on February 13, 2017. The presentation outlines the company's pipeline and business strategy in therapeutic immunology and cancer treatment.